Softwr

Healthcare · head to head

Lunit vs Medscape

Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-
Full reviewWebsite
Medscape logo

Medscape

Healthcare

Medical information, education, and news for healthcare professionals

From
Free
Rated
-
Full reviewWebsite

The short version

  • Only Medscape has a free tier, so it costs nothing to try first.
  • Each has a real cost: Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.; Medscape medscape is free to use but requires mandatory account registration through profreg.medscape.com and login before content can be viewed; the site describes itself as 'a free resource for physicians', restricting the intended audience to registered healthcare professionals rather than the general public (31 Dec 2020 archive capture).
  • They diverge on capability: Lunit covers Lunit INSIGHT MMG, Medscape covers Medical News.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Lunit and Medscape actually diverge.

Attributes where Lunit and Medscape differ
AttributeLunitMedscape
Starting priceOn requestFree
Pricing modelquotefreemium
Free tierNoYes
PlatformsWebWeb, Mobile
FoundedUnknown1996

Identical on both: user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

Only in Medscape

  • Medical News
  • Drug Database
  • Medical Calculators
  • CME Courses
  • Disease Information
  • Specialty Content
  • EHR Systems
  • HIPAA

What people use each for

The jobs each tool is most often brought in to do.

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot Medscape
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot Medscape
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot Medscape
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot Medscape

Medscape

  • Patient Carenot Lunit
  • Medical Recordsnot Lunit
  • Practice Managementnot Lunit
  • Telehealthnot Lunit

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

Medscape

  • Medscape is free to use but requires mandatory account registration through profreg.medscape.com and login before content can be viewed; the site describes itself as 'a free resource for physicians', restricting the intended audience to registered healthcare professionals rather than the general public (31 Dec 2020 archive capture).

Pricing, plan by plan

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

Medscape

Free
  • FreeFree
    • Medical news
    • Drug database
    • CME

Which should you pick?

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.
Lunit review

Choose Medscape if

  • You need medical news.
  • You want to start without paying.
  • You work on Web, Mobile.
  • You also want drug database.
Medscape review

Questions people ask

Is Lunit or Medscape better?
Neither clearly leads. Lunit starts at On request and Medscape at Free, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Lunit or Medscape?
Medscape has a free tier; the other does not. Paid plans start at On request for Lunit and Free for Medscape.
Does Lunit or Medscape run on more platforms?
Lunit runs on Web. Medscape runs on Web, Mobile.
Can I use Medscape for free?
Yes. Medscape has a free tier, so you can try it without paying. Lunit starts at On request.
What is Lunit best used for?
Lunit is most often used for a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated, a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically, an american breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what volpara is bought for, a tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise films. Of those, a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated and a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically are not what Medscape is typically brought in for.
What can Lunit do that Medscape cannot?
Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment. Medscape covers Medical News, Drug Database, Medical Calculators, CME Courses.

Answered from the vendors’ own pages

Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

Share

Related pages

More on Lunit

More on Medscape

Keep looking

Other head to heads